Analyst Ranking
Bottom 3%
#4811 out of 4944 analysts
Average Return
-2.89%
Win Rate
43%111 out of 261
Risk vs Reward
Poor
Good

Brian Abrahams's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
89bio IncETNB
+558.80%$2.67$17.59
2022-05-12 -
2023-05-11
Buy
Pliant Therapeutics IncPLRX
+382.01%$4.67$22.51
2022-05-10 -
2023-05-09
Buy
Ambrx Biopharma IncAMAM
+233.33%$8.40$28.00
2023-10-23 -
2024-03-06
Buy
Mind Medicine IncMNMD
+222.26%$3.01$9.70
2023-03-10 -
2024-03-08
Buy
Ambrx Biopharma IncAMAM
+210.77%$9.01$28.00
2023-11-14 -
2024-03-06
Buy

Brian Abrahams's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Sarepta Therapeutics IncSRPT
31Hold$23.00+4.69%Maintains
a day ago
Biocryst Pharmaceuticals IncBCRX
15Buy$13.00+49.43%Reiterates
18 days ago
Biogen IncBIIB
36Buy$213.00+65.51%Reiterates
21 days ago
Cidara Therapeutics IncCDTX
1Buy$75.00+33.57%Maintains
24 days ago
Acadia Pharmaceuticals IncACAD
1Buy$38.00+68.51%Maintains
25 days ago
Vertex Pharmaceuticals IncVRTX
52Hold$420.00-9.34%Maintains
a month ago
Moonlake ImmunotherapeuticsMLTX
2Buy$67.00+23.66%Reiterates
a month ago
Neurocrine Biosciences IncNBIX
19Buy$145.00+8.12%Reiterates
2 months ago
Regeneron Pharmaceuticals IncREGN
32Buy$943.00+71.45%Reiterates
2 months ago
Contineum Therapeutics IncCTNM
5Buy$31.00+707.29%Reiterates
2 months ago
Aardvark Therapeutics IncAARD
3Buy$20.00+67.22%Maintains
2 months ago
Applied Therapeutics IncAPLT
6Hold$1.50+219.15%Reiterates
2 months ago
Karyopharm Therapeutics IncKPTI
11Buy$33.00+710.81%Maintains
2 months ago
Xenon Pharmaceuticals IncXENE
14Buy$55.00+71.23%Maintains
2 months ago
Ptc Therapeutics IncPTCT
16Buy$58.00+19.51%Maintains
2 months ago
Corbus Pharmaceuticals Holdings IncCRBP
7Buy$58.00+585.58%Maintains
2 months ago
Incyte CorpINCY
20Hold$67.00-2.81%Maintains
3 months ago
Legend Biotech CorpLEGN
1Buy$84.00+99.38%Reiterates
3 months ago
Gh Research PLCGHRS
1Buy$31.00+79.71%Initiates Coverage On
4 months ago
Pliant Therapeutics IncPLRX
13Hold$3.00+111.27%Maintains
5 months ago
Neumora Therapeutics IncNMRA
6Hold$4.00+133.92%Reiterates
5 months ago
Prothena Corp Public Ltd CoPRTA
10Hold$20.00+209.12%Maintains
5 months ago
Gilead Sciences IncGILD
29Hold$90.00-17.28%Maintains
5 months ago
Axsome Therapeutics IncAXSM
2Buy$143.00+27.41%Maintains
5 months ago
Newamsterdam Pharma Co NvNAMS
1Buy$40.00+81.98%Reiterates
6 months ago
Intra Cellular Therapies IncITCI
17Hold$132.00+0.10%Downgrades
6 months ago
Igm Biosciences IncIGMS
15Hold$1.50+18.11%Downgrades
6 months ago
Hookipa Pharma IncHOOK
11Hold$2.00+75.44%Downgrades
7 months ago
Sage Therapeutics IncSAGE
19Hold$4.00-56.24%Upgrades
8 months ago
Galapagos NvGLPG
10Hold$30.00-2.15%Maintains
9 months ago
Marinus Pharmaceuticals IncMRNS
8Hold$1.00+81.82%Maintains
9 months ago
89bio IncETNB
13Hold$12.00+12.68%Maintains
a year ago
Mind Medicine IncMNMD
9Buy$22.00N/AReiterates
a year ago
Ambrx Biopharma IncAMAM
3Buy$32.00N/AMaintains
2 years ago
Karuna Therapeutics IncKRTX
7Buy$225.00N/AMaintains
2 years ago
Enanta Pharmaceuticals IncENTA
14Hold$15.00N/AMaintains
2 years ago
Intercept Pharmaceuticals IncICPT
11Hold$19.00N/AMaintains
2 years ago
Atai Life Sciences NvATAI
3Hold$9.00N/AMaintains
3 years ago
Merus NvMRUS
3Hold$33.00N/AMaintains
4 years ago
Constellation Pharmaceuticals IncCNST
1Hold$34.00N/ADowngrades
4 years ago
Metacrine IncMTCR
1Buy$25.00N/AInitiates Coverage On
5 years ago
Neubase Therapeutics IncNBSE
1Buy$320.00N/AInitiates Coverage On
5 years ago
Celgene CorpCELG
2Buy$118.00N/ADowngrades
7 years ago
Ultragenyx Pharmaceutical IncRARE
2Strong BuyN/AN/AUpgrades
8 years ago
Epizyme IncEPZM
1HoldN/AN/ADowngrades
8 years ago
Alder Biopharmaceuticals IncALDR
1Buy$17.00N/AInitiates Coverage On
8 years ago
Immune Design CorpIMDZ
1Buy$20.00N/AInitiates Coverage On
8 years ago
Avexis IncAVXS
1Hold$92.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.